z-logo
open-access-imgOpen Access
Efficacy of nitazoxanide, tizoxanide and tizoxanide/albendazole sulphoxide combination against Taenia crassiceps cysts
Author(s) -
Francisca Palomares-Alonso,
Juan Carlos Piliado,
Guadalupe Palencia,
Alma OrtizPlata,
Helgi Jung–Cook
Publication year - 2006
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkl463
Subject(s) - albendazole , taenia crassiceps , nitazoxanide , pharmacology , neurocysticercosis , anthelmintic , praziquantel , biology , chemistry , medicine , pathology , immunology , helminths , schistosomiasis , cestoda , ecology
Neurocysticercosis is a common parasitic disease in the CNS in humans caused by the metacestode Taenia solium, with high incidence in developing countries. Albendazole is the drug of choice. However, a wide interindividual variability in the response has been reported. In order to evaluate alternative treatment options, the in vitro efficacy of nitazoxanide, its main metabolite tizoxanide as well as the tizoxanide and albendazole sulphoxide combination was tested against Taenia crassiceps cysts.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom